Trajectory of Lean Body Mass Assessed Using the Modified Creatinine Index and Mortality in Hemodialysis Patients.

Hemodialysis body composition body mass index (BMI) creatinine index end-stage renal disease (ESRD) fat mass lean body mass mortality muscle mass nutritional status obesity paradox prognostication protein-energy wasting (PEW) survival weight loss weight trajectory

Journal

American journal of kidney diseases : the official journal of the National Kidney Foundation
ISSN: 1523-6838
Titre abrégé: Am J Kidney Dis
Pays: United States
ID NLM: 8110075

Informations de publication

Date de publication:
02 2020
Historique:
received: 18 12 2018
accepted: 23 05 2019
pubmed: 30 9 2019
medline: 24 4 2020
entrez: 30 9 2019
Statut: ppublish

Résumé

Although a declining body mass index (BMI) is associated with higher mortality in patients on hemodialysis, BMI cannot distinguish lean body mass from fat mass. It remains unclear whether changes over time in lean body mass are associated with mortality. We examined the prognostic significance of changes in the modified creatinine index, a proxy for lean body mass. Retrospective cohort study. Outpatients (n=349; mean age, 67.4 years; 60% men) undergoing maintenance hemodialysis 3 times a week at a treatment center. Modified creatinine index and BMI trajectories over a 1-year period. All-cause mortality. We calculated the percentage of change in modified creatinine index and BMI over a 1-year period. Patients were categorized according to change in modified creatinine index/BMI: no decline (≥0%) or decline (<0%). Kaplan-Meier and Cox proportional hazard analyses were performed to examine whether modified creatinine index and BMI trajectories were associated with mortality. During follow-up (median, 1,157 days), 79 patients died. Decreasing modified creatinine index (HR, 1.31; 95% CI, 1.11-1.54) and BMI (HR, 1.25; 95% CI, 1.01-1.54) over time, measured as continuous variables and expressed per 1-standard deviation decrease, were independently associated with higher risk for all-cause mortality. The decline in modified creatinine index/no decline in BMI group (HR, 2.14; 95% CI, 1.04-4.45) and the decline in modified creatinine index/decline in BMI group (HR, 3.05; 95% CI, 1.58-5.90) had higher rates of mortality compared to the no decline in modified creatinine index/decline in BMI group. The absence of a direct measure of lean body and fat mass and limited generalizability to non-Japanese hemodialysis populations. The modified creatinine index trajectory is independently associated with mortality and provides additional prognostic information to the BMI trajectory in patients on hemodialysis.

Identifiants

pubmed: 31563467
pii: S0272-6386(19)30859-5
doi: 10.1053/j.ajkd.2019.05.034
pii:
doi:

Substances chimiques

Biomarkers 0
Creatine MU72812GK0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

195-203

Informations de copyright

Copyright © 2019 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Auteurs

Yuta Suzuki (Y)

Department of Rehabilitation Science, Graduate School of Medical Sciences, Kitasato University, Kanagawa, Japan.

Ryota Matsuzawa (R)

Department of Physical Therapy, School of Rehabilitation, Hyogo University of Health Sciences, Hyogo.

Kentaro Kamiya (K)

Department of Rehabilitation, School of Allied Health Sciences, Kitasato University, Kanagawa, Japan.

Keika Hoshi (K)

Department of Hygiene, School of Medicine, Kitasato University, Kanagawa, Japan; National Institute of Public Health Center for Public Health Informatics, Saitama, Japan.

Manae Harada (M)

Department of Rehabilitation Science, Graduate School of Medical Sciences, Kitasato University, Kanagawa, Japan.

Takaaki Watanabe (T)

Department of Rehabilitation Science, Graduate School of Medical Sciences, Kitasato University, Kanagawa, Japan.

Takahiro Shimoda (T)

Department of Rehabilitation Science, Graduate School of Medical Sciences, Kitasato University, Kanagawa, Japan.

Shohei Yamamoto (S)

Department of Rehabilitation Science, Graduate School of Medical Sciences, Kitasato University, Kanagawa, Japan.

Yusuke Matsunaga (Y)

Department of Sleep Medicine, Graduate School of Medical Sciences, Kitasato University, Japan.

Atsushi Yoshida (A)

Department of Hemodialysis Center, Sagami Circulatory Organ Clinic, Kanagawa, Japan.

Atsuhiko Matsunaga (A)

Department of Rehabilitation Science, Graduate School of Medical Sciences, Kitasato University, Kanagawa, Japan. Electronic address: atsuhikonet@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH